Biblio

2022
Zaman AQamar Uz, Hussain S, Zaheer R, Andleeb M, Raza S, Siddiqui T. Positron emission tomography - computed tomography as a monitoring response tool in pre-fibrotic myelofibrosis: A case report. J Pak Med Assoc. 2022;72(3):564-566.
Kitamura W, Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, Fujiwara Y, Usui Y, Fujii K, Fujiwara H, et al. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological S. Int J Hematol. 2022.
Ueda Y, Suzuki K, Kajimoto M, Fujimoto K, Mahendroo M, Ema M, Yamada G, Hara I. Possible testosterone redundancy for 5α-dihydrotestosterone in the masculinization of mouse external genitalia. Exp Anim. 2022.
Bragdon BC, Bennie A, Molinelli A, Liu Y, Gerstenfeld LC. Post natal expression of Prx1 labels appendicular restricted progenitor cell populations of multiple tissues. J Cell Physiol. 2022.
Khan S, Reece D, Atenafu EG, Bhella S, Chen C, Masih-Khan E, Paul H, Prica A, Tiedemann R, Trudel S, et al. Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?. Clin Lymphoma Myeloma Leuk. 2022.
Yang B, Wu S, Yu S, Liang X, Liu Q, Huang F, Liang L. Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation. Eye (Lond). 2022.
Singh A, Spitzer MH, Joy JP, Kaileh M, Qiu X, Nolan GP, Sen R. Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes. Proc Natl Acad Sci U S A. 2022;119(18):e2115567119.
Frenkel B, Gerasimov E, Gustafson A, Gustafson P, McLean G, Ochasi A, Waanders A, Ramaswamy V. Postmortem Tissue Donation: Giving Families the Ability to Choose. J Clin Oncol. 2022:JCO2102839.
Pezoldt J, Wiechers C, Zou M, Litovchenko M, Biocanin M, Beckstette M, Sitnik K, Palatella M, van Mierlo G, Chen W, et al. Postnatal expansion of mesenteric lymph node stromal cells towards reticular and CD34 stromal cell subsets. Nat Commun. 2022;13(1):7227.
Acosta-Medina E, Zorro-Guío OF, Abdala-Vargas NJ, Jacomussi-Alzate L, Figueredo LF, Johnson JM, Patiño-Gómez JG, Ordóñez-Rubiano EG. Postnatal Surgical Correction of Myelomeningoceles: Pre- and Intraoperative Risk Factors Associated with Postoperative Neurological Outcomes. World Neurosurg. 2022.
Xiang Q, Tian F, Xu J, Du X, Zhang S, Guo L, Zhu L, Xie Y, Zang X, Gui Y, et al. Postprandial triglyceride-rich lipoproteins promote the adipogenic differentiation of adipose-derived mesenchymal stem cells via the LRP1/caveolin-1/AKT1 pathway. Biochim Biophys Acta Mol Cell Biol Lipids. 2022:159236.
Guan W, Bellemin S, Bouchet M, Venkatasubramanian L, Guillermin C, Laurençon A, Kabir C, Darnas A, Godin C, Urdy S, et al. Post-transcriptional regulation of transcription factor codes in immature neurons drives neuronal diversity. Cell Rep. 2022;39(13):110992.
Herasevich S, Frank RD, Hogan WJ, Alkhateeb H, Limper AH, Gajic O, Yadav H. Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation. Respir Care. 2022.
Ngwube A, Franay C, Shah N. Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series. Pediatr Hematol Oncol. 2022:1-6.
Bailén R, Pascual-Cascón MJesús, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, et al. Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC. Transplant Cell Ther. 2022.
Luo R, Zhang X, Wang Y, Man Q, Gu W, Tian Z, Wang J. Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT. Orphanet J Rare Dis. 2022;17(1):422.
Broers AEC, de Jong CN, Bakunina K, Hazenberg MD, Kooy Mvan Marwij, de Groot M, van Gelder M, Kuball J, van der Holt B, Meijer E, et al. Posttransplant Cyclophosphamide for Prevention of Graft-versus-Host Disease: The Prospective Randomized HOVON-96 Trial. Blood Adv. 2022.
Mehta RS, Saliba RM, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Nieto Y, Oran B, et al. Post-Transplantation Cyclophosphamide vs Tacrolimus and Methotrexate Graft-versus-Host Disease Prophylaxis For HLA-Matched Donor Transplantation. Transplant Cell Ther. 2022.
Chen K, Andrade-Barazarte H, Liang W, Zhu Q, Guo H, Li Y, Li H, Qian R. Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review. Medicine (Baltimore). 2022;101(52):e32477.
Ren G, Peng Q, Fink T, Zachar V, Porsborg SRiis. Potency assays for human adipose-derived stem cells as a medicinal product toward wound healing. Stem Cell Res Ther. 2022;13(1):249.
Ghassabi A, Motavalli R, Iranzad R, Pourakbari R, Etemadi J, Dolati S, Yousefi M. Potential contribution of the immune system to the emergence of renal diseases. Immunol Lett. 2022.
Cui Y, Huang T, Zhang Z, Yang Z, Hao F, Yuan T, Zhou Z. The potential effect of BMSCs with miR-27a in improving steroid-induced osteonecrosis of the femoral head. Sci Rep. 2022;12(1):21051.
Pinelli R, Biagioni F, Scaffidi E, V Bumah V, Busceti CL, Puglisi-Allegra S, Lazzeri G, Fornai F. The potential effects of nutrients and light on autophagy-mediated visual function and clearance of retinal aggregates. Arch Ital Biol. 2022;160(3-4):115-135.
Köhne M, Behrens CSophie, Stüdemann T, von Bibra C, Querdel E, Shibamiya A, Geertz B, Olfe J, Hüners I, Jockenhövel S, et al. A potential future Fontan modification: preliminary in vitro data of a pressure-generating tube from engineered heart tissue. Eur J Cardiothorac Surg. 2022.
Dehghani A, Zokaei E, Kahani SMohammad, Alavinejad E, Dehghani M, Meftahi GHossein, Afarinesh MReza. The potential impact of Covid-19 on CNS and psychiatric sequels. Asian J Psychiatr. 2022;72:103097.

Pages